American Pharmaceutical, Technoflex form joint venture to make sterile-filled injectable drugs

By E. Janene Geiss

Philadelphia, Dec. 15 - American Pharmaceutical Partners, Inc. and Technoflex SA announced Thursday that they are forming a joint venture to manufacture sterile-filled injectable drugs at American Pharmaceutical's Grand Island, N.Y., facility.

Technoflex will provide its extensive sterile-bag manufacturing and filling expertise and will supply packaging components to the joint venture, while American will contribute its regulatory and marketing expertise and resources, according to a company news release.

The joint venture, Readyflex Solutions LLC, will be majority owned by American Pharmaceutical and will be managed by a joint committee under the supervision of American.

Filled infusion bags represent about 34% of total infusion systems, which also include frozen bags and branded infusion systems, officials said.

"We are very pleased to embark on this strategic joint venture with Technoflex, which will allow APP to leverage its existing regulatory and marketing strengths by simultaneously developing [Abbreviated New Drug Applications] for both the vial and sterile bag presentations of injectable drugs," said Patrick Soon-Shiong, chairman and chief executive officer of American Pharmaceutical, in the release.

"This will provide APP with the ability to supplement its extensive line of hospital injectable vials to provide our customers with an even broader array of cost effective, essential products in both vials and plastic bags," Soon-Shiong added in the release.

Technoflex, based in Bidart, France, manufactures pharmaceutical and medical bags and related molded connectors.

American Pharmaceutical is a Schaumburg, Ill., specialty drug company that develops, manufactures and markets injectable pharmaceutical products, focusing on the oncology, anti-infective and critical care markets.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.